Acetic Acid

Acetic Acid

SCHEMBL6984469

CC(=O)O.OCc1cccc(CO)n1

nearest known ligand 0.53

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOS1 known ✓ P29475 1/20 0.36
NOS2 known ✓ P35228 1/20 0.36
NPSR1 Q6W5P4 1/20 0.53
KCNH2 Q12809 3/20 0.45
PGK1 P00558 1/20 0.43
PGK2 P07205 1/20 0.43
CCR1 P32246 1/20 0.43
BRD4 O60885 1/20 0.40
KDM4E B2RXH2 2/20 0.39
ALOX15 P16050 1/20 0.39
TSHR P16473 1/20 0.39
ACMSD Q8TDX5 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
ADORA2A P29274 2/20 0.38
HRH4 Q9H3N8 1/20 0.38
POLB P06746 1/20 0.37
GRIN2D O15399 1/20 0.36
GRIN3B O60391 1/20 0.36
GRIN1 Q05586 1/20 0.36
GRIN2A Q12879 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9644603 0.85 NPSR1 (0.48) NPSR1KCNH2PGK1PGK2CCR1
SCHEMBL486201 0.85 CCR1 (0.55) NPSR1KCNH2PGK1PGK2CCR1
SCHEMBL22070781 0.83 AKR1B1 (0.41) NPSR1KCNH2PGK1PGK2CCR1
SCHEMBL1054149 0.81 NPSR1 (0.44) NPSR1PGK1PGK2CCR1BRD4
SCHEMBL30952862 0.81 NPSR1 (0.44) NPSR1PGK1PGK2CCR1BRD4
SCHEMBL6984472 0.81 ALDH1A1 (0.47) NPSR1KCNH2PGK1PGK2CCR1
SCHEMBL28383717 0.80 CYP4F2 (0.48) NPSR1KCNH2
SCHEMBL11576989 0.80 NPSR1 (0.47) NPSR1KCNH2PGK1PGK2CCR1
SCHEMBL4043797 0.80 KCNH2 (0.55) NPSR1KCNH2PGK1PGK2CCR1
SCHEMBL949832 0.79 IAPP (0.46) NPSR1KCNH2PGK1PGK2CCR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0985671-B1 PYRIDOCARBAZOLE DERIVATIVES HAVING cGMP-PDE INHIBITORY EFFECT MOCHIDA PHARM CO LTD (JP) 2003-04-02 EP disclosed
US-6197768-B1 THERAPY, PREVENTION ISCHEMIC HEART DISEASE MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2001-03-06 US disclosed
EP-0985671-A1 PYRIDOCARBAZOLE DERIVATIVES HAVING cGMP-PDE INHIBITORY EFFECT MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2000-03-15 EP disclosed
US-6018046-A SELECTIVE ACTION IN INHIBITING CYCLIC GMP-PHOSPHODIESTERASE (CGMP-PDE); PHARMACEUTICALS FOR TREATING DISEASES AGAINST WHICH THE INHIBITORY ACTION IS EFFECTIVE, SUCH AS PULMONARY HYPERTENSION MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2000-01-25 US disclosed